ElteN378

CAS No. 1421366-99-5

ElteN378( —— )

Catalog No. M28977 CAS No. 1421366-99-5

ElteN378 is a highly potent synthetic inhibitor of FKBP12 with Ki of 0.5 nM, a low atomic weight ligand with affinity comparable to that of the macrolide Rapamycin.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 393 Get Quote
10MG 581 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1674 Get Quote
500MG 3348 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ElteN378
  • Note
    Research use only, not for human use.
  • Brief Description
    ElteN378 is a highly potent synthetic inhibitor of FKBP12 with Ki of 0.5 nM, a low atomic weight ligand with affinity comparable to that of the macrolide Rapamycin.
  • Description
    ElteN378 is a highly potent synthetic inhibitor of FKBP12 with Ki of 0.5 nM, a low atomic weight ligand with affinity comparable to that of the macrolide Rapamycin.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    Antioxidant
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1421366-99-5
  • Formula Weight
    378.46
  • Molecular Formula
    C23H26N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C([C@@H]1N(C(C(C2=CC=CC=C2)=O)=O)CCCC1)NCCCC3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Flávia Franceli de Brito Passos, et al. Involvement of Cholinergic and Opioid System in γ-Terpinene-Mediated Antinociception. Evid Based Complement Alternat Med. 2015;2015:829414.
molnova catalog
related products
  • Cbz-B3A

    Cbz-B3A is a potent inhibitor of mTORC1 signalling, inhibits phosphorylation of eIF4E-binding protein 1 (4EBP1) and blocks translation by 68%.

  • mTOR inhibitor 10

    A novel potent, selective mTOR inhibitor with biochemical IC50 of 21.7 nM for mTORC1.

  • ML239

    ML239 is a potent and selective inhibitor of breast cancer stem cells, with an IC50 of 1.16 μM.